GlassScriptPhysician profile
Adnan Pervez
NPI 1013017748
$3,628.26
in general payments reported to CMS, 2019-2025
16 companies · $1,271 in 2025
The $1,271 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $242 · 2021: $107 · 2022: $286 · 2023: $1,217 · 2024: $362 · 2025: $1,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,392 · Food and Beverage: $1,328 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,392.41 |
| Food and Beverage | $1,327.55 |
| Education | $129.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,517.01 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $208.68 | 2020-2025 | |
| Philips North America LLC | $176.12 | 2019-2023 | |
| United Therapeutics Corporation | $170.24 | 2021-2023 | |
| Glaxosmithkline, LLC. | $126.21 | 2019-2023 | Arexvy, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $114.14 | 2025 | |
| Vapotherm INC | $76.40 | 2020 | |
| Inogen, INC. | $58.46 | 2022-2024 | |
| Ethicon INC. | $35.04 | 2022 | |
| Resmed Corp | $33.48 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.35 | 2021 | |
| Genentech USA, INC. | $21.24 | 2019 | |
| Insmed, INC. | $20.43 | 2025 | Arikayce |
| Shionogi INC | $19.44 | 2022 | |
| Nabriva Therapeutics, Plc | $16.10 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Pervez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.